During the malignant transformation of nasopharyngeal epithelial cells, EBV-infected host cells accumulate somatic mutations, and a small part of the mutated genes are presented to MHC to form tumor neoantigens and are recognized by activated CD8+ T cells, stimulating the tumor immune response [99]. Here, HLA-C is linked to neoplasm.